| IBV | infectious bronchitis vaccine; infectious bronchitis virus |
|---|---|
| IDT | immune diffusion test; instillation delivery time; intradermal typhoid [vaccine] |
| IPV | inactivated poliomyelitis vaccine or virus; infectious pustular vaginitis; infectious pustular vulvo... |
| ISCO | immunostimulating complex [vaccine] |
| IVV | influenza virus vaccine; intravenous vasopressin |
| rubella virus vaccine | A live virus vaccine prepared from duck embryo or human diploid cell culture infected with rubella virus; administered as a single subcutaneous injection. See: measles, mumps, and rubella vaccine. (05 Mar 2000) |
|---|---|
| MMR vaccine | <drug> The mumps, measles and rubella vaccine is recommended in all infants. Typically given twice, 15 months and at 4-6 years. (27 Sep 1997) |
| plague vaccine | A suspension of killed yersinia pestis used for immunizing people in enzootic plague areas. (12 Dec 1998) |
| whooping-cough vaccine | See: diphtheria toxoid, tetanus toxoid, and pertussis vaccine. (05 Mar 2000) |
| multivalent vaccine | A vaccine prepared from cultures of two or more strains of the same species or microorganism. Synonym: multivalent vaccine. (05 Mar 2000) |
| mumps vaccine | A live attenuated virus vaccine of chick embryo origin, used for routine immunization of children and for immunization of adolescents and adults who have not had mumps or been immunised with live mumps vaccine. Children are usually immunised with measles-mumps-rubella combinatiom vaccine. (12 Dec 1998) |
| mumps virus vaccine | Vaccine containing live, attenuated mumps virus prepared in chick embryo cell cultures. See: measles, mumps, and rubella vaccine. (05 Mar 2000) |
| pneumococcal vaccine | Vaccine comprised of purified capsular polysaccharide antigen from 23 types of Streptococcus pneumoniae (representing those types responsible for most of the reported pneumococcal diseases in the U.S.). (05 Mar 2000) |
| poliovirus vaccine | A suspension of formalin-inactivated poliovirus, types I, II, and III, grown in monkey kidney cell tissue culture, used in the united states only for immunization of immunologically deficient patients and for primary immunization of unimmunised adults at risk. (12 Dec 1998) |
| polyvalent vaccine | A vaccine prepared from cultures of two or more strains of the same species or microorganism. Synonym: multivalent vaccine. (05 Mar 2000) |
| crystal violet vaccine | See: hog cholera vaccines. (05 Mar 2000) |
| Haemophilus influenza b vaccine | <virology> A vaccination that is given to infants to protect against infection with haemophilus influenza b, an important cause of neonatal sepsis. Typically administered at 2, 4, 6 and 15 months. Children who are aged 15 months to 5 years, who have not received the vaccine, should be given a single injection of haemophilus b conjugate vaccine. Acronym: HIB (26 Mar 1998) |
| Haemophilus influenzae type B vaccine | A conjugate of oligosaccharides of the capsular antigen of H. Influenzae type B and diphtheria CRM protein. (05 Mar 2000) |
| Haffkine's vaccine | A killed culture of Vibrio cholerae in two strengths, a weaker one for the initial inoculation and a stronger one for the second inoculation 7 to 10 days after the first, a killed plague bacillus (Yersinia pestis) vaccine. (05 Mar 2000) |
| sabin vaccine | Oral Polio virus Vaccine (OPV). The polio virus in opv is attenuated (weakened). The sabin vaccine is named after the american virologist albert sabin. See immunization, polio. (12 Dec 1998) |